nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—ADRA1A—polycystic ovary syndrome	0.813	1	CbGaD
Naphazoline—NISCH—adrenal cortex—polycystic ovary syndrome	0.0025	0.0859	CbGeAlD
Naphazoline—Phentolamine—ADRA1D—polycystic ovary syndrome	0.0022	0.239	CrCbGaD
Naphazoline—NISCH—uterus—polycystic ovary syndrome	0.00206	0.0707	CbGeAlD
Naphazoline—NISCH—pituitary gland—polycystic ovary syndrome	0.00202	0.0694	CbGeAlD
Naphazoline—NISCH—adipose tissue—polycystic ovary syndrome	0.00202	0.0691	CbGeAlD
Naphazoline—Phentolamine—ADRA1B—polycystic ovary syndrome	0.00188	0.204	CrCbGaD
Naphazoline—NISCH—adrenal gland—polycystic ovary syndrome	0.00181	0.062	CbGeAlD
Naphazoline—NISCH—female gonad—polycystic ovary syndrome	0.00169	0.0578	CbGeAlD
Naphazoline—NISCH—vagina—polycystic ovary syndrome	0.00168	0.0575	CbGeAlD
Naphazoline—Terbinafine—CYP11A1—polycystic ovary syndrome	0.00138	0.15	CrCbGaD
Naphazoline—Phentolamine—ADRA1A—polycystic ovary syndrome	0.00126	0.137	CrCbGaD
Naphazoline—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.00114	0.0392	CbGeAlD
Naphazoline—ADRA2C—endometrium—polycystic ovary syndrome	0.00102	0.035	CbGeAlD
Naphazoline—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000966	0.0331	CbGeAlD
Naphazoline—ADRA2C—uterus—polycystic ovary syndrome	0.000941	0.0323	CbGeAlD
Naphazoline—ADRA2C—pituitary gland—polycystic ovary syndrome	0.000924	0.0317	CbGeAlD
Naphazoline—ADRA2C—adipose tissue—polycystic ovary syndrome	0.000921	0.0316	CbGeAlD
Naphazoline—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000867	0.0297	CbGeAlD
Naphazoline—ADRA2C—adrenal gland—polycystic ovary syndrome	0.000826	0.0283	CbGeAlD
Naphazoline—ADRA2A—endometrium—polycystic ovary syndrome	0.000815	0.028	CbGeAlD
Naphazoline—ADRA2C—female gonad—polycystic ovary syndrome	0.00077	0.0264	CbGeAlD
Naphazoline—ADRA2C—vagina—polycystic ovary syndrome	0.000765	0.0262	CbGeAlD
Naphazoline—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000752	0.0258	CbGeAlD
Naphazoline—ADRA2A—uterus—polycystic ovary syndrome	0.000751	0.0258	CbGeAlD
Naphazoline—Tolazoline—ADRA1A—polycystic ovary syndrome	0.000745	0.0809	CrCbGaD
Naphazoline—ADRA2A—pituitary gland—polycystic ovary syndrome	0.000738	0.0253	CbGeAlD
Naphazoline—ADRA2A—adipose tissue—polycystic ovary syndrome	0.000735	0.0252	CbGeAlD
Naphazoline—Terbinafine—CYP19A1—polycystic ovary syndrome	0.000715	0.0775	CrCbGaD
Naphazoline—ADRA2A—adrenal gland—polycystic ovary syndrome	0.000659	0.0226	CbGeAlD
Naphazoline—ADRA2A—female gonad—polycystic ovary syndrome	0.000614	0.0211	CbGeAlD
Naphazoline—ADRA2A—vagina—polycystic ovary syndrome	0.000611	0.0209	CbGeAlD
Naphazoline—Propranolol—ADRB3—polycystic ovary syndrome	0.000605	0.0656	CrCbGaD
Naphazoline—ADRA2A—endocrine gland—polycystic ovary syndrome	0.000571	0.0196	CbGeAlD
Naphazoline—Propranolol—ADRB2—polycystic ovary syndrome	0.00023	0.025	CrCbGaD
Naphazoline—Propranolol—CYP1A1—polycystic ovary syndrome	0.000197	0.0214	CrCbGaD
Naphazoline—ADRA2C—Metabolism—AKR1C1—polycystic ovary syndrome	3.87e-05	0.000261	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	3.86e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.85e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—POMC—polycystic ovary syndrome	3.85e-05	0.00026	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.83e-05	0.000258	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	3.82e-05	0.000258	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.78e-05	0.000255	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	3.76e-05	0.000254	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FST—polycystic ovary syndrome	3.75e-05	0.000253	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.73e-05	0.000252	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.71e-05	0.00025	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.7e-05	0.00025	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.68e-05	0.000248	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LHB—polycystic ovary syndrome	3.66e-05	0.000247	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	3.65e-05	0.000246	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.6e-05	0.000243	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.58e-05	0.000242	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—SULT2A1—polycystic ovary syndrome	3.57e-05	0.000241	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—IGF1—polycystic ovary syndrome	3.55e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—AKT2—polycystic ovary syndrome	3.54e-05	0.000239	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	3.51e-05	0.000237	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FST—polycystic ovary syndrome	3.51e-05	0.000237	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.49e-05	0.000235	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.47e-05	0.000234	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.46e-05	0.000234	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.46e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—RRM2—polycystic ovary syndrome	3.45e-05	0.000233	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	3.44e-05	0.000232	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SCT—polycystic ovary syndrome	3.43e-05	0.000232	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LHB—polycystic ovary syndrome	3.42e-05	0.000231	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	3.42e-05	0.000231	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	3.41e-05	0.00023	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.39e-05	0.000229	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—SERPINE1—polycystic ovary syndrome	3.37e-05	0.000227	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.37e-05	0.000227	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.35e-05	0.000226	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.34e-05	0.000226	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—YAP1—polycystic ovary syndrome	3.33e-05	0.000225	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	3.32e-05	0.000224	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—IGF1—polycystic ovary syndrome	3.31e-05	0.000224	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT2—polycystic ovary syndrome	3.31e-05	0.000223	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.28e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	3.25e-05	0.000219	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.24e-05	0.000219	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3.23e-05	0.000218	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	3.23e-05	0.000218	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—FGF18—polycystic ovary syndrome	3.22e-05	0.000217	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SCT—polycystic ovary syndrome	3.21e-05	0.000216	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NAMPT—polycystic ovary syndrome	3.2e-05	0.000216	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	3.2e-05	0.000216	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—RBP4—polycystic ovary syndrome	3.19e-05	0.000215	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	3.17e-05	0.000214	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP11A1—polycystic ovary syndrome	3.16e-05	0.000213	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	3.15e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—SERPINE1—polycystic ovary syndrome	3.15e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.14e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	3.13e-05	0.000211	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	3.11e-05	0.00021	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	3.07e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.06e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	3.05e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.03e-05	0.000204	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—FGF18—polycystic ovary syndrome	3.01e-05	0.000203	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	3e-05	0.000203	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	2.99e-05	0.000202	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKR1C3—polycystic ovary syndrome	2.98e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RBP4—polycystic ovary syndrome	2.98e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	2.98e-05	0.000201	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	2.94e-05	0.000198	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP17A1—polycystic ovary syndrome	2.94e-05	0.000198	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.94e-05	0.000198	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.92e-05	0.000197	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	2.92e-05	0.000197	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	2.9e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	2.85e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.83e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	2.83e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.83e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	2.81e-05	0.00019	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	2.81e-05	0.00019	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	2.81e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	2.8e-05	0.000189	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—YAP1—polycystic ovary syndrome	2.78e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	2.78e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.77e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GAB1—polycystic ovary syndrome	2.75e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	2.72e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	2.7e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	2.69e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	2.69e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.67e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.67e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	2.63e-05	0.000178	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.63e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.63e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	2.63e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—INSR—polycystic ovary syndrome	2.63e-05	0.000177	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.61e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	2.61e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	2.6e-05	0.000176	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	2.6e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	2.6e-05	0.000175	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	2.57e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.57e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	2.57e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	2.56e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—TH—polycystic ovary syndrome	2.54e-05	0.000171	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.49e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	2.49e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—SLC2A4—polycystic ovary syndrome	2.47e-05	0.000167	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.46e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	2.44e-05	0.000165	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.43e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PGR—polycystic ovary syndrome	2.43e-05	0.000164	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	2.42e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	2.42e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	2.42e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	2.42e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.4e-05	0.000162	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	2.39e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	2.38e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.33e-05	0.000157	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP19A1—polycystic ovary syndrome	2.32e-05	0.000157	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	2.32e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	2.31e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	2.29e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	2.26e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PLAT—polycystic ovary syndrome	2.26e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GHRL—polycystic ovary syndrome	2.26e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.25e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.24e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	2.23e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.18e-05	0.000147	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.18e-05	0.000147	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—VEGFA—polycystic ovary syndrome	2.16e-05	0.000146	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ATF1—polycystic ovary syndrome	2.16e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.15e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	2.13e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	2.13e-05	0.000144	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	2.12e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	2.12e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	2.11e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.1e-05	0.000142	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.09e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	2.07e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—TH—polycystic ovary syndrome	2.06e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.03e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.03e-05	0.000137	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	2.01e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	2e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	1.99e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	1.99e-05	0.000134	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	1.98e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	1.98e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.98e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.98e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	1.97e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	1.97e-05	0.000133	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.9e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.9e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	1.89e-05	0.000127	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.88e-05	0.000127	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	1.87e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.87e-05	0.000126	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	1.86e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.84e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	1.84e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	1.84e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.83e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.77e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	1.77e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	1.76e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	1.75e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	1.75e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.74e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	1.74e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	1.73e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.73e-05	0.000117	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	1.72e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	1.71e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	1.7e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	1.68e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.66e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.65e-05	0.000111	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.64e-05	0.00011	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	1.62e-05	0.000109	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	1.62e-05	0.000109	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	1.61e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	1.6e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	1.6e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	1.54e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	1.52e-05	0.000103	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	1.52e-05	0.000102	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.52e-05	0.000102	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	1.49e-05	0.0001	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	1.46e-05	9.82e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.44e-05	9.74e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	1.42e-05	9.57e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.42e-05	9.56e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	1.42e-05	9.55e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	1.41e-05	9.5e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	1.4e-05	9.42e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	1.39e-05	9.37e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—INS—polycystic ovary syndrome	1.39e-05	9.37e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	1.36e-05	9.17e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.34e-05	9.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	1.32e-05	8.89e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	1.3e-05	8.76e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	1.25e-05	8.43e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	1.24e-05	8.39e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.21e-05	8.19e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	1.21e-05	8.18e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	1.2e-05	8.11e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	1.2e-05	8.11e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.19e-05	8.02e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	1.17e-05	7.88e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	1.16e-05	7.83e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	1.15e-05	7.76e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.14e-05	7.7e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	1.13e-05	7.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.13e-05	7.61e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—INS—polycystic ovary syndrome	1.13e-05	7.61e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	1.12e-05	7.58e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	1.12e-05	7.57e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	1.1e-05	7.45e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.07e-05	7.2e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.06e-05	7.15e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.02e-05	6.89e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	1.02e-05	6.85e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	9.85e-06	6.64e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.82e-06	6.62e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.81e-06	6.62e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	9.49e-06	6.4e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	9.43e-06	6.36e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.33e-06	6.29e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	9.2e-06	6.2e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	9.12e-06	6.16e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	9.12e-06	6.15e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.66e-06	5.85e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	8.59e-06	5.8e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.85e-06	5.3e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	7.51e-06	5.07e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.34e-06	4.95e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	6.98e-06	4.71e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.41e-06	4.33e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.96e-06	4.02e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	5.43e-06	3.66e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	5.07e-06	3.42e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	4.44e-06	2.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	4.12e-06	2.78e-05	CbGpPWpGaD
